Cohance Lifesciences Limited
COHANCE
Rangering i aksjer
#6386
Headquartered in Hyderabad, Cohance Lifesciences Limited operates as a... Headquartered in Hyderabad, Cohance Lifesciences Limited operates as a pharmaceutical enterprise, with primary expertise in contract development and manufacturing (CDMO) services. Its business scope also includes the creation of active pharmaceutical ingredients (APIs) and diverse specialty chemicals. The company, previously known as Suven Pharmaceuticals Limited, underwent a corporate rebranding following its amalgamation with Cohance Lifesciences, a transition officially effective May 1, 2025.
Aksjekurs
$5.05
Sist synkronisert: 2026-10-19
Markedsverdi
$1.93B
Endring (1 dag)
-1.44%
Endring (1 år)
-57.38%
Land
IN
Handel Cohance Lifesciences Limited (COHANCE)
Kategori
Healthcare
Utbytteavkastning for Cohance Lifesciences Limited (COHANCE)
Cohance Lifesciences Limited (aksjesymbol: COHANCE) sin utbytteavkastning (TTM) per 2024-03-31 er: 0.00%
Gjennomsnittlig utbytteavkastning de siste 5 årene: 0.51%
Gjennomsnittlig utbytteavkastning de siste 5 årene: 0.51%
Utbytteavkastning for Cohance Lifesciences Limited (COHANCE) fra 2019 til 2026
Utbytteavkastning ved slutten av hvert år (TTM)
| År | Utbytteavkastning | Endre |
|---|---|---|
| 2026 (TTM) | 0.00% | 0.00% |
| 2025 | 0.00% | 0.00% |
| 2024 | 0.00% | -100.00% |
| 2023 | 1.69% | 160.00% |
| 2022 | 0.65% | 225.00% |
| 2021 | 0.20% | -93.33% |
| 2020 | 3.00% | 455.56% |
| 2019 | 0.54% | 0.00% |
Utbytteavkastning (TTM) for lignende selskaper eller konkurrenter
| Selskap | Utbytteavkastning | Land |
|---|---|---|
| 0.00% |
DE
|
|
| 0.00% |
DE
|
|
| 0.00% |
JP
|
|
| 0.00% |
CH
|
|
| 0.91% |
IN
|
